236 related articles for article (PubMed ID: 7698988)
1. Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms.
Bikfalvi A; Klein S; Pintucci G; Quarto N; Mignatti P; Rifkin DB
J Cell Biol; 1995 Apr; 129(1):233-43. PubMed ID: 7698988
[TBL] [Abstract][Full Text] [Related]
2. The NH2-terminal extension of high molecular weight forms of basic fibroblast growth factor (bFGF) is not essential for the binding of bFGF to nuclear chromatin in transfected NIH 3T3 cells.
Gualandris A; Coltrini D; Bergonzoni L; Isacchi A; Tenca S; Ginelli B; Presta M
Growth Factors; 1993; 8(1):49-60. PubMed ID: 8448039
[TBL] [Abstract][Full Text] [Related]
3. Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells.
Quarto N; Talarico D; Florkiewicz R; Rifkin DB
Cell Regul; 1991 Sep; 2(9):699-708. PubMed ID: 1660309
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of fibroblast growth factor (FGF) receptor-1 mRNA and protein by two molecular forms of basic FGF. Modulation of FGFR-1 mRNA stability.
Estival A; Monzat V; Miquel K; Gaubert F; Hollande E; Korc M; Vaysse N; Clemente F
J Biol Chem; 1996 Mar; 271(10):5663-70. PubMed ID: 8621430
[TBL] [Abstract][Full Text] [Related]
5. Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2.
Klein S; Bikfalvi A; Birkenmeier TM; Giancotti FG; Rifkin DB
J Biol Chem; 1996 Sep; 271(37):22583-90. PubMed ID: 8798427
[TBL] [Abstract][Full Text] [Related]
6. Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin.
Moscatelli D; Quarto N
J Cell Biol; 1989 Nov; 109(5):2519-27. PubMed ID: 2553749
[TBL] [Abstract][Full Text] [Related]
7. Studies on FGF-2: nuclear localization and function of high molecular weight forms and receptor binding in the absence of heparin.
Rifkin DB; Moscatelli D; Roghani M; Nagano Y; Quarto N; Klein S; Bikfalvi A
Mol Reprod Dev; 1994 Sep; 39(1):102-4; discussion 104-5. PubMed ID: 7999354
[TBL] [Abstract][Full Text] [Related]
8. Activation of a transfected FGFR-1 receptor in Madin-Darby epithelial cells results in a reversible loss of epithelial properties.
Migdal M; Soker S; Yarden Y; Neufeld G
J Cell Physiol; 1995 Feb; 162(2):266-76. PubMed ID: 7529769
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation.
Wieder R; Fenig E; Wang H; Wang Q; Paglin S; Menzel T; Gabrilove J; Fuks Z; Yahalom J
J Cell Physiol; 1998 Dec; 177(3):411-25. PubMed ID: 9808150
[TBL] [Abstract][Full Text] [Related]
10. Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.
Rusnati M; Coltrini D; Caccia P; Dell'Era P; Zoppetti G; Oreste P; Valsasina B; Presta M
Biochem Biophys Res Commun; 1994 Aug; 203(1):450-8. PubMed ID: 8074689
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential.
Dini G; Funghini S; Witort E; Magnelli L; Fanti E; Rifkin DB; Del Rosso M
J Cell Physiol; 2002 Oct; 193(1):64-72. PubMed ID: 12209881
[TBL] [Abstract][Full Text] [Related]
12. Autocrine regulation of cell growth and transformation by basic fibroblast growth factor.
Yayon A; Klagsbrun M
Cancer Metastasis Rev; 1990 Nov; 9(3):191-202. PubMed ID: 2292136
[TBL] [Abstract][Full Text] [Related]
13. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.
Yayon A; Ma YS; Safran M; Klagsbrun M; Halaban R
Oncogene; 1997 Jun; 14(25):2999-3009. PubMed ID: 9223663
[TBL] [Abstract][Full Text] [Related]
14. Interaction of high-molecular-weight basic fibroblast growth factor with endothelium: biological activity and intracellular fate of human recombinant M(r) 24,000 bFGF.
Gualandris A; Urbinati C; Rusnati M; Ziche M; Presta M
J Cell Physiol; 1994 Oct; 161(1):149-59. PubMed ID: 7929600
[TBL] [Abstract][Full Text] [Related]
15. Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals.
Arese M; Chen Y; Florkiewicz RZ; Gualandris A; Shen B; Rifkin DB
Mol Biol Cell; 1999 May; 10(5):1429-44. PubMed ID: 10233154
[TBL] [Abstract][Full Text] [Related]
16. Expression of two different forms of fibroblast growth factor receptor 1 in different mouse tissues and cell lines.
Bernard O; Li M; Reid HH
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7625-9. PubMed ID: 1715572
[TBL] [Abstract][Full Text] [Related]
17. Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin.
Yayon A; Klagsbrun M
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5346-50. PubMed ID: 2164679
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican.
Steinfeld R; Van Den Berghe H; David G
J Cell Biol; 1996 Apr; 133(2):405-16. PubMed ID: 8609172
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cell growth and transformation by doxycycline-regulated FGF-2 expression in NIH-3T3 cells.
Gualandris A; Arese M; Shen B; Rifkin DB
J Cell Physiol; 1999 Nov; 181(2):273-84. PubMed ID: 10497306
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of capillary endothelial cells for basic fibroblast growth factor-induced paracrine signaling.
Lee TH; Lee HC; Son YS; Kang MA; Park MJ; Nam MJ; Lee SH; Hong SI
Endothelium; 2006; 13(3):191-203. PubMed ID: 16840175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
